omega-3 fatty acids and non-alcoholic fatty liver disease
Authors
abstract
background: omega-3 fatty acids have established beneficial effects for cardiovascular disease. the use of omega-3 supplements for patients with non-alcoholic fatty liver disease (nafld) was proposed. the purpose of this study was to review the relationship between omega-3 fatty acids intake and nafld. methods: in this study, the terms such as nafld, omega-3 fatty acids, docosahexanoic acid, and eicosapentanoic acid were searched in pubmed search engine. 15 studies on nafld and omega-3 were found. four of these studies were not fully available. three studies were not strong in terms of design. therefore, 8 studies were chosen. findings: the results showed that omega-3 is a regulator of gene expression in the liver. human studies have established that consumption of omega-3 have a role in reducing the hepatic steatosis, improving insulin sensitivity and decrease the inflammatory marker. more clinical trials should be conducted to confirm these findings. conclusion: omega-3 fatty acids may improve symptoms associated with nafld, but more studies should be done in this area.
similar resources
Clinical Manifestations and Diagnosis of Non-Alcoholic Fatty Liver Disease
Background & Objective: Nonalcoholic fatty liver diseases (NAFLD) is the major cause of hepatocellular carcinoma and increases the risk of mortality. Understanding the trends of its clinical and biochemical changes is essential to identify patients with NAFLD that are at the greatest risk of nonalcoholic steatohepatitis (NASH) and cirrhosis in Iran. M...
full textOmega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial
BACKGROUND Non-alcoholic fatty liver disease (NAFLD) is a liver manifestation of metabolic syndrome since obesity and insulin resistance are the main pathogenic contributors for both conditions. NAFLD carries increased risk of atherosclerosis and cardiovascular diseases. There is an urgent need to find effective and safe therapy for children and adults with NAFLD. Data from research and clinica...
full textOmega-3 Polyunsaturated Fatty Acids in the Treatment of Non-Alcoholic Fatty Liver Disease: Are They So Good?
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent hepatic problem in Western and Asian countries where it can affect more than 30% of people [1]. NAFLD pathological characteristic is a fat infiltration of the hepatocytes (hepatic steatosis) in subjects who are mild or no alcohol drinkers and do not have other secondary causes of hepatic lipid accumulation. In one fifth of affected...
full textEffectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials
BACKGROUND Non-alcoholic fatty liver disease (NAFLD) is a clinical syndrome with the main characteristic of diffuse liver cells with fatty changes. The clinical evolution of NAFLD includes simple non-alcoholic fatty liver, non-alcoholic steatohepatitis (NASH), liver fibrosis and cirrhosis, and even hepatocellular carcinoma. METHODS AND FINDINGS We conducted this review to identify the effecti...
full textNon-alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease describes a range of conditions caused by a build-up of fat within liver cells. It is very common and in many cases is linked to being obese or overweight. Most people with non-alcoholic fatty liver disease do not develop serious liver problems. In some people, the build-up of fat in the liver can lead to serious liver disease. However, all people with non-alco...
full textNon-Alcoholic Fatty Liver Disease
Results: The term “non-alcoholic fatty liver disease” covers cases of a wide spectrum of severity, ranging from bland fatty liver without any inflammation and with little or no tendency to progress all the way to non-alcoholic steato hepatitis (NASH) with inflammatory reactions and hepatocyte damage, with or without fibrosis. Some 5% to 20% of patients with NAFLD develop NASH, which undergoes a...
full textMy Resources
Save resource for easier access later
Journal title:
تحقیقات نظام سلامتجلد ۹، شماره ۳، صفحات ۲۵۹-۲۶۸
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023